A Study of SLV-154 in People With Solid Tumor Cancer

Full Title

A Phase 1 Dose-Escalation Study of SLV-154 in Subjects with Metastatic Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Roisin O’Cearbhaill’s office at 646-888-4227.

Protocol

25-316

Phase

Phase I (phase 1)

Disease Status

Relapsed or Refractory

Investigator

Co-Investigators

ClinicalTrials.gov ID

NCT06771219